Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
These changes collectively reduce the risk of cardiovascular events such as heart attacks and strokes
Regular follow-up ensures the safest, most effective use
Young, P., Finn, B
Phase 2 trials demonstrated A1C reductions of up to 2.02% in participants with type 2 diabetes, bringing average levels from 8.1% down to 6.08%
Studies show that patients taking Wegovy achieve an average weight loss of 15% from the initial body weight (35 lbs in people with a starting weight of 232 lbs) after 68 weeks (1 year 4 months) on the drug
US$ 24.71
US$ 23.65
US$ 25.07
US$ 27.89
US$ 25.77
US$ 27.46
US$ 27.31
US$ 21.04
US$ 27.64
US$ 24.92
